<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
STATEMENT OF OPERATIONS AND BALANCE SHEET OF ALLERGAN SPECIALTY THERAPEUTICS,
INC.
</LEGEND>
<MULTIPLIER> 1,000
       
                             
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          DEC-31-1998
<PERIOD-START>                             JAN-01-1998
<PERIOD-END>                               DEC-31-1998
<CASH>                                               0
<SECURITIES>                                   158,667
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                               158,667
<PP&E>                                               0
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                                 165,137
<CURRENT-LIABILITIES>                            4,804
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                            34
<OTHER-SE>                                     160,299
<TOTAL-LIABILITY-AND-EQUITY>                   165,137
<SALES>                                              0
<TOTAL-REVENUES>                                 9,043
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                                43,339
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                (34,296)
<INCOME-TAX>                                     2,512
<INCOME-CONTINUING>                            (36,808)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (36,808)
<EPS-PRIMARY>                                  $(11.24)
<EPS-DILUTED>                                  $(11.24)